290 related articles for article (PubMed ID: 17997058)
1. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
[TBL] [Abstract][Full Text] [Related]
2. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
3. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
4. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index.
Rungruxsirivorn T; Panyakamlerd K; Trerattanachart S; Taechakraichana N
J Med Assoc Thai; 2006 Sep; 89(9):1362-7. PubMed ID: 17100370
[TBL] [Abstract][Full Text] [Related]
7. Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen.
Taechakraichana N; Intraragsakul A; Panyakhamlerd K; Numchaisrika P; Limpaphayom K
J Med Assoc Thai; 1997 Oct; 80(10):626-30. PubMed ID: 10904564
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiles of progestogen effects in the postmenopausal breast.
Wood CE; Register TC; Cline JM
Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
[TBL] [Abstract][Full Text] [Related]
10. The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1 expression in postmenopausal vaginal epithelium.
Sağsöz N; Yücel A; Noyan V; Bozdoğan O
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):61-6. PubMed ID: 15955616
[TBL] [Abstract][Full Text] [Related]
11. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
12. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of insulin-like growth factor-I-induced changes in messenger ribonucleic acid expression in cultured porcine granulosa cells: possible role of insulin-like growth factor-I in angiogenesis.
Grado-Ahuir JA; Aad PY; Ranzenigo G; Caloni F; Cremonesi F; Spicer LJ
J Anim Sci; 2009 Jun; 87(6):1921-33. PubMed ID: 19251926
[TBL] [Abstract][Full Text] [Related]
14. Gene expression pattern and hormonal regulation of small proline-rich protein 2 family members in the female mouse reproductive system during the estrous cycle and pregnancy.
Tan YF; Sun XY; Li FX; Tang S; Piao YS; Wang YL
Reprod Nutr Dev; 2006; 46(6):641-55. PubMed ID: 17169311
[TBL] [Abstract][Full Text] [Related]
15. Ezrin is a key element in the human vagina.
Fadiel A; Lee HH; Demir N; Richman S; Iwasaki A; Connell K; Naftolin F
Maturitas; 2008 May; 60(1):31-41. PubMed ID: 18486367
[TBL] [Abstract][Full Text] [Related]
16. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
Johnson SR; Ettinger B; Macer JL; Ensrud KE; Quan J; Grady D
Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
[TBL] [Abstract][Full Text] [Related]
18. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
19. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
20. Involvement of growth factors in induction of persistent proliferation of vaginal epithelium of mice exposed neonatally to diethylstilbestrol.
Sato T; Fukazawa Y; Ohta Y; Iguchi T
Reprod Toxicol; 2004 Nov; 19(1):43-51. PubMed ID: 15336711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
